Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Spatializer Audio Laboratories, Inc.

Market Cap 4.71M 4.11M 3.8M 3.56M 6.67M 444M 6.72M 45.12M 17.48M 219M 17.69M 17.31M 760M P/E 2024
-0.28x
P/E 2025 -0.1x
Enterprise Value 35.32K 30.8K 28.48K 26.69K 49.98K 3.33M 50.38K 338K 131K 1.64M 133K 130K 5.7M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
-
Yield 2024 *
-
Yield 2025 -

Financials

2024 2025
Net sales - -
Net income -9.57M -8.35M -7.72M -7.24M -13.55M -903M -13.66M -91.67M -35.52M -445M -35.94M -35.17M -1.54B -8.77M -7.65M -7.07M -6.63M -12.41M -827M -12.51M -83.98M -32.54M -407M -32.92M -32.22M -1.41B
Net Debt -2.24M -1.95M -1.81M -1.69M -3.17M -211M -3.2M -21.46M -8.31M -104M -8.41M -8.23M -361M -4.68M -4.08M -3.77M -3.53M -6.62M -441M -6.67M -44.78M -17.35M -217M -17.56M -17.18M -754M
Logo Spatializer Audio Laboratories, Inc.
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from cannabinoids and taps into its global network of scientists and oncology physicians. The Company is advancing its pipeline of new-generation of naturally occurring and synthetic compounds. It is developing product candidates that target skin-related ailments common among cancer patients, including radiodermatitis, pruritus, rashes and dry skin, as well as indications such as chemotherapy-induced peripheral neuropathy, with future areas of focus that may include depression, pain and anxiety.
Employees
-
Sector
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!